Deritas 7.5 mg Tablet 10's
₹432*
MRP ₹480
10% off
₹408*
MRP ₹480
15% CB
₹72 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Deritas 7.5 mg Tablet 10's belongs to the group of medications called ‘antimuscarinic' or 'antispasmodics' primarily used in the treatment of overactive bladder (OAB) symptoms. Overactive bladder is a condition in which the urinary bladder muscles constrict uncontrollably thereby causing an urgent need to urinate, frequent urination, and inability to control urination.
Deritas 7.5 mg Tablet 10's contains ‘Darifenacin’ that relaxes the urinary bladder muscles which in turn decreases the activity of the overactive bladder. In an overactive bladder, muscle contractions occur before the full expansion of the bladder causing the patient to have frequent urges to urinate. Deritas 7.5 mg Tablet 10's stops these sudden contractions of urinary bladder muscles thereby enabling control over urination. Thus, it increases the amount and volume of urination that can be held by your bladder.
Take Deritas 7.5 mg Tablet 10's as prescribed by your doctor. You are advised to take Deritas 7.5 mg Tablet 10's for as long as your doctor has prescribed it for you depending on your medical conditions. You may experience dryness in the mouth, constipation, nausea, blurred vision, indigestion, and headache. Most of these side effects of Deritas 7.5 mg Tablet 10's do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Before starting Deritas 7.5 mg Tablet 10's, please inform your doctor if you have any allergy with this Deritas 7.5 mg Tablet 10's or any other medicine or any type of foods. Talk to your doctor if you have glaucoma, liver disease. If you have trouble passing urine or slow clearing your stomach, then inform your doctor. Do not start, stop, or change the dose of Deritas 7.5 mg Tablet 10's without checking with your doctor. Inform your doctor if you are pregnant or plan on becoming pregnant. Inform your doctor if you are breast-feeding. You will need to discuss any risks to your baby.
Deritas 7.5 mg Tablet 10's contains ‘Darifenacin’ that belongs to the class of medications called 'anticholinergics' or ‘antimuscarinic’. It can decrease the activity of the overactive bladder. In an overactive bladder, muscle contractions occur before the full expansion of the bladder causing the patient to have frequent urges to urinate. Deritas 7.5 mg Tablet 10's can stop these sudden contractions of bladder muscles. It enables control over urination and increases the amount of urine that can be held by your bladder.
Before starting Deritas 7.5 mg Tablet 10's, please inform your doctor if you have any allergy with this Deritas 7.5 mg Tablet 10's or any other medicine or any type of foods. Talk to your doctor if you have glaucoma, liver disease. If you have trouble passing urine or slow clearing your stomach, then inform your doctor. Do not start, stop, or change the dose of Deritas 7.5 mg Tablet 10's without checking with your doctor. A very bad reaction called angioedema (swelling of the face, hands, eyes, lips, throat, tongue, or difficulty in breathing and swallowing) has happened with Deritas 7.5 mg Tablet 10's. Get medical help immediately if you have any of these symptoms. Sometimes, this may be life-threatening. Avoid driving and doing other activities that require concentration until you see how Deritas 7.5 mg Tablet 10's affects you. Inform your doctor if you are pregnant or plan on becoming pregnant. Inform your doctor if you are breast-feeding. You will need to discuss any risks to your baby.
Drug-Drug Interactions: Deritas 7.5 mg Tablet 10's may interact with antiviral medicines (amprenavir, atazanavir, boceprevir, indinavir), antipsychotic medicines (brexpiprazole), anticancer (ceritinib), medicines for HIV / AIDS (cobicistat), antifungal drugs (ketoconazole), idelalisib, ketoconazole, blood pressure-lowering pills (mibefradil), medicines used to treat brain disorder (donepezil).
Drug-Food Interactions: Do not take grapefruit or grapefruit juice while using Deritas 7.5 mg Tablet 10's.
Drug-Disease Interactions: Deritas 7.5 mg Tablet 10's should be used with caution in patients with urinary retention (inability to urinate), brain disease, liver disease, gastric problems.
Overactive bladder (OAB): In normal conditions, when the urinary bladder is filled with urine, it sends a message to the brain that an individual is ready to urinate. During the urination process, bladder muscles contract which ultimately leads to a uniform flow of urine. Contrary to this, in an Overactive bladder (OAB), the urinary bladder muscles start contracting before the urine is filled in the urinary bladder, thereby causing frequent urges to urinate. Deritas 7.5 mg Tablet 10's prevents this sudden bladder muscle contractions and increasing the volume and amount of urine that the bladder can hold. Thus, Deritas 7.5 mg Tablet 10's helps to control the release of urine and helps reduce symptoms of OAB like a strong urge to urinate, frequent urination, and reduced urine flow.
Country of origin
Manufacturer/Marketer address
Alcohol
Caution
Avoid taking alcohol as it may increase the risk of dizziness.
Pregnancy
Unsafe
Deritas 7.5 mg Tablet 10's is a category C medicine. It should be used in pregnant women if the benefits outweigh the risks.
Breast Feeding
Caution
Deritas 7.5 mg Tablet 10's should be used in breastfeeding mothers only if clinically needed.
Driving
Caution
Deritas 7.5 mg Tablet 10's may cause dizziness and blurred vision and sleepiness. So, avoid driving or operating heavy machinery after using Deritas 7.5 mg Tablet 10's.
Liver
Caution
Deritas 7.5 mg Tablet 10's should be used with caution in patients with liver diseases
Kidney
Caution
Deritas 7.5 mg Tablet 10's should be used with caution in patients with kidney diseases.
Children
Unsafe
Not recommended for use in children below 18 years of age due to a lack of data on safety and efficacy.
Product Substitutes